Nature Medicine 2001 Alan Dove - Abstracts
| Nature Medicine 2001 Alan Dove | |||||
| Title | Subject | Authors | |||
|---|---|---|---|---|---|
| FDA tightens human oversight. | Health | Alan Dove | |||
| Is investment in bioterrorism research warrented? | Health | Alan Dove | |||
| New addiction research unlikely to be applied. | Health | Alan Dove | |||
| New class of HIV drugs show promise. | Health | Alan Dove | |||
| New rats set physiologists' hearts aflutter. | Health | Alan Dove | |||
| Patents not key barrier to AIDS therapy. | Health | Alan Dove | |||
| Proteomics: basic research climbs aboard. | Health | Alan Dove | |||
| Report predicts burgeoning vaccine markets. | Health | Alan Dove | |||
| Stem cell researchers ponder worst-case scenario. | Health | Alan Dove | |||
| US throws money at TSE research.(transmissible spongiform encephalopathie)(Statistical Data Included) | Health | Alan Dove | |||
This website is not affiliated with document authors or copyright owners. This page is provided for informational purposes only. Unintentional errors are possible.